Membrane-bound mucins of the airway mucosal surfaces are densely decorated with keratan sulfate: revisiting their role in the Lung's innate defense.
airway defense
keratan sulfate
membrane tethered mucins
periciliary layer
Journal
Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124
Informations de publication
Date de publication:
03 05 2021
03 05 2021
Historique:
received:
14
07
2020
revised:
24
08
2020
accepted:
08
09
2020
pubmed:
22
10
2020
medline:
1
4
2022
entrez:
21
10
2020
Statut:
ppublish
Résumé
Understanding the basic elements of the airway mucosal surfaces and how they form a functional barrier is essential in understanding disease initiation, progression, pathogenesis and ultimately treating chronic lung diseases. Using primary airway epithelial cell cultures, atomic force microscopy (AFM), multiangle light scattering and quartz crystal micro balance with dissipation monitoring techniques, here we report that the membrane bound mucins (MBMs) found in the periciliary layer (PCL) of the airway surface are densely decorated with keratan sulfate (KS). AFM and immunoblotting show that the KS sidechains can be removed enzymatically with keratanase II (KII) treatment, and the antibody accessibility for B2729 (MUC1), MUCH4 (MUC4) and OC125 (MUC16) was substantially enhanced. Light scattering analysis confirmed that KII treatment removed ~40% of the mass from the mucin fractions. Surface binding experiments indicated that MBMs were able to pack into a tighter conformation following KS removal, suggesting that negatively charged KS sidechains play a role in mucin-mucin repulsion and contribute to "space filling" in the PCL. We also observed that soluble filtrate from the common airway pathogen Pseudomonas aeruginosa is capable of stripping KS from MBMs. Altogether, our findings indicate that KS glycosylation of MBMs may play an important role in the integrity of the airway mucosal barrier and its compromise in disease.
Identifiants
pubmed: 33083824
pii: 5909502
doi: 10.1093/glycob/cwaa089
pmc: PMC8091473
doi:
Substances chimiques
Mucins
0
Keratan Sulfate
9056-36-4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
436-443Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL103940
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Adv Drug Deliv Rev. 2009 Feb 27;61(2):86-100
pubmed: 19166889
Biochem J. 2002 Feb 1;361(Pt 3):537-46
pubmed: 11802783
Scand J Respir Dis. 1977 Apr;58(2):65-79
pubmed: 404701
Cell Microbiol. 2010 Aug;12(8):1158-73
pubmed: 20331639
Proc Am Thorac Soc. 2004;1(1):42-6
pubmed: 16113411
Am J Respir Crit Care Med. 1997 Jul;156(1):173-7
pubmed: 9230743
Lancet. 1971 Jan 30;1(7692):236-7
pubmed: 4099895
Int J Chron Obstruct Pulmon Dis. 2014 Jan 24;9:139-50
pubmed: 24493923
J Clin Med. 2017 Nov 29;6(12):
pubmed: 29186029
Am J Physiol Lung Cell Mol Physiol. 2009 Jan;296(1):L92-L100
pubmed: 18931053
Infect Immun. 1989 Oct;57(10):3066-71
pubmed: 2777373
Biorheology. 1980;17(1-2):163-8
pubmed: 7407344
Curr Opin Immunol. 2001 Feb;13(1):89-95
pubmed: 11154923
J Biol Chem. 2003 Aug 1;278(31):28619-34
pubmed: 12734200
Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L181-7
pubmed: 11133508
J Clin Invest. 2014 Jul;124(7):3047-60
pubmed: 24892808
FASEB J. 2011 Jul;25(7):2325-32
pubmed: 21427214
Mucosal Immunol. 2017 Mar;10(2):395-407
pubmed: 27435107
J Virol. 2004 Dec;78(24):13755-68
pubmed: 15564484
Front Biosci (Landmark Ed). 2016 Jun 01;21:1260-77
pubmed: 27100505
Annu Rev Physiol. 2008;70:431-57
pubmed: 17850209
Eur Respir J. 2018 Dec 6;52(6):
pubmed: 30361244
Pulm Pharmacol Ther. 2012 Dec;25(6):415-9
pubmed: 22198062
Dis Markers. 2013;34(4):257-67
pubmed: 23396293
Am J Respir Cell Mol Biol. 2014 Sep;51(3):446-54
pubmed: 24693944
Am J Respir Cell Mol Biol. 2006 Feb;34(2):135-41
pubmed: 16195536
Biophys J. 1999 Jul;77(1):533-41
pubmed: 10388778
N Engl J Med. 2017 Sep 7;377(10):911-922
pubmed: 28877023
Am J Respir Crit Care Med. 2018 Feb 15;197(4):481-491
pubmed: 29099608
Arch Intern Med. 1970 Sep;126(3):417-23
pubmed: 5450933
J Proteome Res. 2014 Jul 3;13(7):3349-59
pubmed: 24850311
Am J Physiol Lung Cell Mol Physiol. 2000 Jun;278(6):L1118-28
pubmed: 10835316
Mucosal Immunol. 2016 Nov;9(6):1442-1454
pubmed: 27072609
Glycobiology. 1998 Mar;8(3):269-76
pubmed: 9451036
Am J Respir Crit Care Med. 2015 Jul 15;192(2):182-90
pubmed: 25909230
Glycoconj J. 2002 May-Jun;19(4-5):275-85
pubmed: 12975606
Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60
pubmed: 18202344
Am J Respir Cell Mol Biol. 1995 Dec;13(6):748-56
pubmed: 7576713
Sci Transl Med. 2019 Apr 3;11(486):
pubmed: 30944166
J Virol. 2014 Nov;88(22):13221-30
pubmed: 25187545
Science. 2012 Aug 24;337(6097):937-41
pubmed: 22923574
Methods Mol Med. 2005;107:183-206
pubmed: 15492373
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Med Microbiol. 1999 Jun;48(6):551-557
pubmed: 10359304
Eur J Respir Dis Suppl. 1980;111:29-34
pubmed: 6938407
Respir Res. 2005 Apr 01;6:26
pubmed: 15804356
Mucosal Immunol. 2013 Mar;6(2):379-92
pubmed: 22929560